Merck KGaA's Share Price Faces Scrutiny Amid Earnings Growth

Merck KGaA (XTRA:MRK) has delivered a solid 28.7% return over the past year, which puts fresh attention on whether the current share price lines up with what the business earns.

The stock currently trades around €133.95, and investors are wondering how this move stacks up against the company's earnings power.

With the agreed acquisition of Bio-Techne expected to close between late 2026 and early 2027, there may be changes in Merck KGaA's life science earnings profile, including future margins and cash flow mix once the combined operation is in place.